Optellum develops an imaging biomarker for smart lung cancer detection.
Optellum has raised €16M across 2 funding rounds from 7 investors, most recently a Series A round in Sep 2022. Based in Oxford, UK; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-09-27 | Series A | €15M | Black Opal Ventures,family office of Sir Martin & Lady Audrey Wood,Intuitive Ventures,IQ Capital,Mercia,St John’s College | View deal → |
| 2019-07-01 | Seed | €1.1M | Luminous Ventures | View deal → |
